Cargando…
A renal cell carcinoma tumorgraft platform to advance precision medicine
Renal cell carcinoma (RCC) encompasses a heterogenous group of tumors, but representative preclinical models are lacking. We previously showed that patient-derived tumorgraft (TG) models recapitulate the biology and treatment responsiveness. Through systematic orthotopic implantation of tumor sample...
Autores principales: | Elias, Roy, Tcheuyap, Vanina T., Kaushik, Akash K., Singla, Nirmish, Gao, Ming, Torras, Oscar Reig, Christie, Alana, Mulgaonkar, Aditi, Woolford, Layton, Stevens, Christina, Kettimuthu, Kavitha Priya, Pavia-Jimenez, Andrea, Boroughs, Lindsey K., Joyce, Allison, Dakanali, Marianna, Notgrass, Hollis, Margulis, Vitaly, Cadeddu, Jeffrey A., Pedrosa, Ivan, Williams, Noelle S., Sun, Xiankai, DeBerardinis, Ralph J., Öz, Orhan K., Zhong, Hua, Seshagiri, Somasekar, Modrusan, Zora, Cantarel, Brandi L., Kapur, Payal, Brugarolas, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762721/ https://www.ncbi.nlm.nih.gov/pubmed/34818533 http://dx.doi.org/10.1016/j.celrep.2021.110055 |
Ejemplares similares
-
PD-L1 detection using (89)Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response
por: Vento, Joseph, et al.
Publicado: (2019) -
Determinants of renal cell carcinoma invasion and metastatic competence
por: Kim, Kangsan, et al.
Publicado: (2021) -
Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma
por: Garcia, Patrick L., et al.
Publicado: (2013) -
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
por: Kaushik, Akash K., et al.
Publicado: (2022) -
Single-cell RNA sequencing identifies distinct mouse medial ganglionic eminence cell types
por: Chen, Ying-Jiun J., et al.
Publicado: (2017)